Dong S. Kim
Wondu, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Data collection framework for electronic medical record-based real-world data to evaluate the effectiveness and safety of cancer drugs: a nationwide real-world study of the Korean Cancer Study Group.
Journal: Therapeutic advances in medical oncology
Published: February 06, 2022
Ramucirumab plus paclitaxel as a second-line treatment in HER2-positive gastric cancer: subgroup analysis of a nationwide, real-world study in Korea (KCSG-ST19-16).
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: November 01, 2021
Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16).
Journal: Therapeutic advances in medical oncology
Published: April 30, 2021
Development of Antibiotic Classification for Measuring Antibiotic Usage in Korean Hospitals Using a Modified Delphi Method.
Journal: Journal of Korean medical science
Published: May 07, 2020
Redefining the role of etoposide in first-line treatment of peripheral T-cell lymphoma.
Journal: Blood advances
Published: July 21, 2017
Incidence, mortality, and causes of death in physician-diagnosed primary Sjögren's syndrome in Korea: A nationwide, population-based study.
Journal: Seminars in arthritis and rheumatism
Published: November 15, 2016
Towards Actualizing the Value Potential of Korea Health Insurance Review and Assessment (HIRA) Data as a Resource for Health Research: Strengths, Limitations, Applications, and Strategies for Optimal Use of HIRA Data.
Journal: Journal of Korean medical science
Published: September 04, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026